BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1371379)

  • 1. Lymphoproliferative disorder of granular lymphocytes. A heterogeneous disease.
    McDaniel HL; MacPherson BR; Tindle BH; Lunde JH
    Arch Pathol Lab Med; 1992 Mar; 116(3):242-8. PubMed ID: 1371379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative disorder of granular lymphocytes. More questions than answers.
    McKenna RW
    Arch Pathol Lab Med; 1992 Mar; 116(3):235-7. PubMed ID: 1371378
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
    Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
    Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of lymphocyte phenotype and T cell receptor genotype in Felty's syndrome.
    Meliconi R; Kingsley GH; Pitzalis C; Sakkas L; Panayi GS
    J Rheumatol; 1992 Jul; 19(7):1058-64. PubMed ID: 1380988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
    Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
    Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the T cell receptor in the lymphoproliferative disease of granular lymphocytes: superantigen activation of clonal CD3+ granular lymphocytes.
    Zambello R; Trentin L; Facco M; Cerutti A; Sancetta R; Milani A; Raimondi R; Tassinari C; Agostini C; Semenzato G
    Cancer Res; 1995 Dec; 55(24):6140-5. PubMed ID: 8521405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the major phenotype of large granular T-cell lymphoproliferative disorder.
    Sun T; Brody J; Koduru P; Vinciguerra V; Weiselberg L; Marino J; Chaudhri F; Papps J; Erickson R
    Am J Clin Pathol; 1992 Nov; 98(5):516-21. PubMed ID: 1283056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of human CD4-CD8-CD3- thymocytes highly purified from postnatal thymus.
    Hori T; Spits H
    J Immunol; 1991 Apr; 146(7):2116-21. PubMed ID: 1826017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy.
    Antonaci S; Polignano A; Ottolenghi A; Tortorella C; Schena FP
    Cytobios; 1992; 69(276):27-34. PubMed ID: 1374697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3 negative "small agranular lymphocytes" are natural killer cells.
    Inverardi L; Witson JC; Fuad SA; Winkler-Pickett RT; Ortaldo JR; Bach FH
    J Immunol; 1991 Jun; 146(11):4048-52. PubMed ID: 1827820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of CD16 and CD56 expression in persistent expansions of CD3+NKa+ lymphocytes are predictive for clonal T-cell receptor gene rearrangements. The Yorkshire Leukaemia Group.
    Sivakumaran M; Richards SJ; Hunt KM; Steed AJ; Bynoe AG; Morgan MM; Pyrah R; Roberts BE; Scott CS
    Br J Haematol; 1991 Jul; 78(3):368-77. PubMed ID: 1714758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.
    Starling GC; Davidson SE; Nimmo JC; Beard ME; Hart DN
    Clin Exp Immunol; 1989 Dec; 78(3):396-401. PubMed ID: 2532991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA.
    Wood GS; Dubiel C; Mueller C; Abel EA; Hoppe RT; Edinger A; Weissman I; Warnke RA
    Am J Pathol; 1991 Jun; 138(6):1545-52. PubMed ID: 1828937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
    Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
    Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
    Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
    J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonally expanded CD3+, CD4-, CD8- cells bearing the alpha/beta or the gamma/delta T-cell receptor in patients with the lymphoproliferative disease of granular lymphocytes.
    Pandolfi F; Foa R; De Rossi G; Zambello R; Chisesi T; di Celle PF; Migone N; Casorati G; Scarselli E; Ensoli F
    Clin Immunol Immunopathol; 1991 Sep; 60(3):371-83. PubMed ID: 1830831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell lymphoproliferative disorder complicated by a natural killer cell lymphoproliferative disorder of granular lymphocytes associated with T-cell gene rearrangement: case report and review of the literature.
    Dunphy CH; Martin AW; Dunphy FR
    Mod Pathol; 1995 Oct; 8(8):803-10. PubMed ID: 8552567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aggressive natural killer cell lymphoproliferative disease of large granular lymphocytes with leukemia-like clinical course in the terminalstage].
    Tsukada T; Ohno T; Morita K; Otsuji H; Sekine T; Nishikawa M; Kobayashi T; Kita K; Shirakawa S; Namba K
    Rinsho Ketsueki; 1991 Feb; 32(2):162-6. PubMed ID: 2027242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.